New human microbiome research tool
One of the most complex human organs is the digestive tract: Here, the body comes into contact with all manner of diet-derived compounds and with countless bacteria.
Scientists from the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg in collaboration with colleagues at the Luxembourg Institute of Health and the University of Arizona in the United States have now proven that a model of the human gut they have developed and patented - HuMiX - is representative of the actual conditions and processes that occur within our intestines.
With HuMiX, the researchers can analyse the complex interactions between human cells and bacteria, predict their effects on health or disease onset, and study the action of probiotics and drugs. The researchers publish their findings today in the journal Nature Communications (DOI: 10.1038/NCOMMS11535).
In HuMiX, the "Human Microbial Cross-talk" model, human intestinal cells and bacteria can be cultivated together in a very small space under representative conditions. The apparatus, no bigger than a beer mat, consists of three chambers. The top chamber is the supply level, from which nutrients continuously flow down to the cell cultures below. Human cells grow on a very thin membrane in the middle chamber, while bacteria grow in the lowest chamber.
"With HuMiX, we can observe interaction of bacteria in real-time as they communicate with human intestinal cells," says Prof. Paul Wilmes, head of the LCSB Ecosystems Biology Group and inventor of HuMiX.
For their tests confirming the validity of HuMiX experiments, the researchers employed pure cultures of various bacterial strains. "Using cutting-edge analytical methods established at the LCSB, we then studied how the gene activity and metabolism of intestinal epithelial cells change depending on the bacterial strain used in HuMiX," Wilmes explains.
"A comparison of our data with results from other research groups who obtained theirs from humans or animals showed strong agreement." That means HuMiX delivers a very accurate portrayal of the cellular and molecular processes taking place in the human gut. "With HuMiX we can also study processes so far inaccessible by existing experimental methods," Wilmes adds.
Dr. Pranjul Shah, first author of the publication and co-inventor of the HuMiX device, names one example of a metabolic process the LCSB researchers discovered with HuMiX: "In a co-culture of intestinal cells and a certain strain of the bacterial species Lactobacillus rhamnosus, we determined that production of a messenger of the nervous system, specifically the neurotransmitter gamma-aminobutyric acid or GABA, is stimulated in intestinal cells, indicating a mechanism by which the intestine may be communicating with the brain."
Scientists had already seen evidence of this effect several years earlier in the brain of mice born with a completely sterile gut (which was devoid of all intestinal flora), when their gut was inoculated with similar Lactobacillus strains. "The ability of HuMiX to provide such responses can be attributed to the unique capability of the HuMiX model to allow cultivation of anaerobic bacteria along with human intestinal cells", highlights Shah.
"We can now study these and similar effects at an unprecedented level of precision thanks to HuMiX," Paul Wilmes continues. "There are clues, for example, that inflammatory processes can play a role in the onset of neurodegenerative diseases such as Parkinson's. In HuMiX, we can introduce distinct bacterial species or whole communities into the artificial gut model whether these organisms trigger or slow down inflammation, or even introduce immune cells and neurons together with the bacteria."
In their publication, the scientists present evidence that HuMiX is a suitable tool for understanding a range of molecular processes involved in the interaction between human cells and bacteria. Furthermore, Wilmes sees a benefit not only for basic research, but also for clinical application: "With HuMiX, we can now also analyse how probiotics, dietary compounds or drugs affect human physiology. We expect to see concrete indicators of how these therapeutics need to be refined in order to work better in the future."
The HuMiX project has received support from the Luxembourg National Research Fund's ATTRACT, CORE, Inter mobility, Accompanying Measures 2c, Proof-of-Concept and AFR funding programmes.
Thomas Klein | EurekAlert!
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy